Beam Therapeutics
beamtx.comBeam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam team is: • A community of fearless innovators • Rigorous and honest in our research • Listening with open minds • Committed to each other
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the North Carolina Biotechnology Center network.
Something looks off?
Open jobs at Beam Therapeutics
On-site & Remote
Job function
Seniority
Salary